Bioorthogonal Oxime Ligation Mediated In Vivo Cancer Targeting

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Current cancer targeting methods using biological interactions face limitations like cancer cell heterogeneity and immunogenicity.
• Bioorthogonal chemical conjugation offers a promising alternative for precise in vivo cancer targeting.

Purpose of the Study:

• To develop and evaluate a novel in vivo cancer targeting strategy utilizing bioorthogonal oxime ligation.
• To improve the specificity and efficiency of nanoparticle-based cancer targeting.

Main Methods:

• Introducing oxyamine groups onto 4T1 murine breast cancer cells via liposome delivery.
• Surface-functionalizing poly(ethylene glycol)-polylactide (PEG-PLA) nanoparticles with aldehyde groups as targeting ligands.
• Utilizing bioorthogonal oxime ligation between oxyamine and aldehyde groups for targeted delivery.

Main Results:

• Demonstrated successful introduction of artificial oxyamine targets onto cancer cells.
• Achieved specific and efficient chemical conjugation between targeted cancer cells and PEG-PLA nanoparticles.
• Showcased improved in vivo cancer targeting efficacy through this bioorthogonal strategy.

Conclusions:

• Bioorthogonal oxime ligation provides a robust and efficient platform for in vivo cancer targeting.
• This chemical conjugation approach overcomes limitations associated with traditional biological targeting methods.
• The developed strategy holds potential for advancing targeted cancer therapies.